162 related articles for article (PubMed ID: 21814032)
21. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl.
Behrens A; Aguzzi A
Trends Neurosci; 2002 Mar; 25(3):150-4. PubMed ID: 11852147
[TBL] [Abstract][Full Text] [Related]
22. Nonneuronal cellular prion protein.
Fournier JG
Int Rev Cytol; 2001; 208():121-60. PubMed ID: 11510567
[TBL] [Abstract][Full Text] [Related]
23. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
24. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
25. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
26. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
[TBL] [Abstract][Full Text] [Related]
27. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
29. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
[TBL] [Abstract][Full Text] [Related]
30. The prion's elusive reason for being.
Aguzzi A; Baumann F; Bremer J
Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
[TBL] [Abstract][Full Text] [Related]
31. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
[TBL] [Abstract][Full Text] [Related]
32. Prion infection: seeded fibrillization or more?
Birkmann E; Riesner D
Prion; 2008; 2(2):67-72. PubMed ID: 19098436
[TBL] [Abstract][Full Text] [Related]
33. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
Bate C; Williams A
J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
[TBL] [Abstract][Full Text] [Related]
34. The PrP(C) C1 fragment derived from the ovine A136R154R171PRNP allele is highly abundant in sheep brain and inhibits fibrillisation of full-length PrP(C) protein in vitro.
Campbell L; Gill AC; McGovern G; Jalland CM; Hopkins J; Tranulis MA; Hunter N; Goldmann W
Biochim Biophys Acta; 2013 Jun; 1832(6):826-36. PubMed ID: 23474307
[TBL] [Abstract][Full Text] [Related]
35. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
[TBL] [Abstract][Full Text] [Related]
36. Microglia in Prion Diseases: Angels or Demons?
Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
[TBL] [Abstract][Full Text] [Related]
37. Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival.
Machado CF; Beraldo FH; Santos TG; Bourgeon D; Landemberger MC; Roffé M; Martins VR
J Biol Chem; 2012 Dec; 287(52):43777-88. PubMed ID: 23132868
[TBL] [Abstract][Full Text] [Related]
38. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
39. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
40. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
